We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Adtalem (ATGE) Q3 Earnings Top Estimates, 2024 Guidance Up
Read MoreHide Full Article
Adtalem Global Education Inc. (ATGE - Free Report) reported impressive results for third-quarter fiscal 2024, wherein earnings and revenues surpassed their respective Zacks Consensus Estimate. Also, both metrics increased year over year.
Revenue growth and operational efficiencies, which were partially offset by investments in Growth with Purpose initiatives, helped ATGE post solid margins. Impressively, its Growth with Purpose strategy allowed the company to expand access to high-quality, in-demand programs.
Earnings, Revenues & Margins Discussion
Adjusted earnings per share (EPS) of $1.50 topped the consensus mark of $1.15 by 30.4% and surged 32.7% from $1.13 in the year-ago quarter.
Adtalem Global Education Inc. Price, Consensus and EPS Surprise
Revenues of $412.7 million beat the consensus mark of $392 million by 5.3% and increased 11.8% year over year. For the fiscal third quarter, enrollment of total students rose 7.8% year over year to 85,809.
Adjusted operating income rose 23% from the prior-year quarter’s levels to $89.8 million. Adjusted operating margin increased 200 basis points (bps) to 21.8%.
Adjusted EBITDA was $107.1 million, up 24.6% from the prior-year quarter’s levels. Adjusted EBITDA margin expanded 260 bps to 25.9% year over year.
Segment Details
Chamberlain: Revenues in the segment were up 13.8% from the year-ago quarter’s levels, totaling $170.3 million. Total student enrollment increased 9% to 37,985 students, driven by growth in pre-licensure and post-licensure nursing programs as well as high persistence.
Adjusted operating income grew 9.5% from the prior-year quarter’s levels to $43.3 million. Adjusted operating margin, however, contracted 100 bps to 25.4%.
Adjusted EBITDA was $50.5 million, up 12.3% from the prior-year quarter’s levels. Adjusted EBITDA margins, however, fell 40 bps to 29.6% due to increased investments in marketing, student support services to enhance academic outcomes and other costs.
Walden: The segment generated revenues of $150.6 million, which grew 13.3% year over year. Total student enrollment in the quarter increased 8.4% year over year to 42,751 students. This was backed by growth in healthcare, slightly offset by non-healthcare programs as well as high persistence.
Adjusted operating income came in at $31.9 million, up 29.4% from a year ago. Adjusted operating margin expanded 270 basis points to 21.2%.
Adjusted EBITDA was $35.9 million, up 28.9% from the prior-year period’s levels. Adjusted EBITDA margins improved 290 bps to 23.8%.
Medical and Veterinary: Revenues in the segment increased 6.1% to $91.7 million from the year-ago quarter’s figure. Total student enrollment, however, fell 4.5% from the prior-year quarter’s levels to 5,073 students due to declines at the medical schools.
Adjusted operating income increased 35.9% from the prior-year quarter’s figure to $23 million. Adjusted operating margin expanded 550 basis points to 25%.
Adjusted EBITDA was $27 million, up 30.3% from the prior-year quarter’s levels. Adjusted EBITDA margins surged 540 bps to 29.4%.
Liquidity & Cash Flow
As of Mar 31, 2024, Adtalem had cash and cash equivalents of $179.8 million compared with $273.7 million at the end of fiscal 2023. Long-term debt was $648.1 million, down from $695.1 million at the end of fiscal 2023. Trailing 12-month net debt to adjusted EBITDA was 1.3x at March 2024-end versus 1.5x at 2023-end.
For the first nine months of fiscal 2024, net cash provided by operating activities (continuing operations) totaled $246.8 million compared with $149.8 million in the year-ago period. Free cash flow in the quarter was $142.1 million compared with $98.2 million a year ago.
Raised Fiscal 2024 Guidance
Adtalem now expects revenues in the range of $1.56-$1.58 billion, up from the prior expectation of $1.52-$1.56 billion. The updated guidance is up from the prior-year figure of $1.45 billion.
Adjusted EPS is now expected to be in the range of $4.80-$5.00 per share, up from the prior estimate of $4.55-$4.75. In the year-ago period, the company reported an adjusted EPS of $4.21.
Leggett & Platt, Incorporated (LEG - Free Report) reported tepid first-quarter 2024 results, wherein earnings and net sales missed the Zacks Consensus Estimate. The metrics declined on a year-over-year basis due to persistent weak demand in most of the markets served and lower price realization.
Leggett significantly reduced its second-quarter dividend to 5 cents from the prior-year figure of 46 cents. The company noted that the move has been undertaken to free up capital to accelerate the deleveraging of its balance sheet and solidify long-held financial strength. The dividend will be paid on Jul 15, 2024, to shareholders of record on Jun 14.
Strategic Education, Inc. (STRA - Free Report) , or SEI, reported stellar results for first-quarter 2024. Its quarterly earnings and revenues topped the Zacks Consensus Estimate and increased year over year.
The quarterly results reflect solid growth across the company’s three reportable segments, attributable to continued enrollment growth in the U.S. Higher Education segment, especially employer-affiliated enrollments, and total enrollment improvement in the Australia/New Zealand segment.
Mohawk Industries, Inc. (MHK - Free Report) reported impressive earnings in first-quarter 2024 (ended Mar 30). Its earnings surpassed the Zacks Consensus Estimate and improved from the prior year on the back of lower input costs, less restructuring expenses and productivity gains.
On the other hand, net sales declined on a year-over-year basis but marginally beat the consensus mark.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Adtalem (ATGE) Q3 Earnings Top Estimates, 2024 Guidance Up
Adtalem Global Education Inc. (ATGE - Free Report) reported impressive results for third-quarter fiscal 2024, wherein earnings and revenues surpassed their respective Zacks Consensus Estimate. Also, both metrics increased year over year.
Revenue growth and operational efficiencies, which were partially offset by investments in Growth with Purpose initiatives, helped ATGE post solid margins. Impressively, its Growth with Purpose strategy allowed the company to expand access to high-quality, in-demand programs.
Earnings, Revenues & Margins Discussion
Adjusted earnings per share (EPS) of $1.50 topped the consensus mark of $1.15 by 30.4% and surged 32.7% from $1.13 in the year-ago quarter.
Adtalem Global Education Inc. Price, Consensus and EPS Surprise
Adtalem Global Education Inc. price-consensus-eps-surprise-chart | Adtalem Global Education Inc. Quote
Revenues of $412.7 million beat the consensus mark of $392 million by 5.3% and increased 11.8% year over year. For the fiscal third quarter, enrollment of total students rose 7.8% year over year to 85,809.
Adjusted operating income rose 23% from the prior-year quarter’s levels to $89.8 million. Adjusted operating margin increased 200 basis points (bps) to 21.8%.
Adjusted EBITDA was $107.1 million, up 24.6% from the prior-year quarter’s levels. Adjusted EBITDA margin expanded 260 bps to 25.9% year over year.
Segment Details
Chamberlain: Revenues in the segment were up 13.8% from the year-ago quarter’s levels, totaling $170.3 million. Total student enrollment increased 9% to 37,985 students, driven by growth in pre-licensure and post-licensure nursing programs as well as high persistence.
Adjusted operating income grew 9.5% from the prior-year quarter’s levels to $43.3 million. Adjusted operating margin, however, contracted 100 bps to 25.4%.
Adjusted EBITDA was $50.5 million, up 12.3% from the prior-year quarter’s levels. Adjusted EBITDA margins, however, fell 40 bps to 29.6% due to increased investments in marketing, student support services to enhance academic outcomes and other costs.
Walden: The segment generated revenues of $150.6 million, which grew 13.3% year over year. Total student enrollment in the quarter increased 8.4% year over year to 42,751 students. This was backed by growth in healthcare, slightly offset by non-healthcare programs as well as high persistence.
Adjusted operating income came in at $31.9 million, up 29.4% from a year ago. Adjusted operating margin expanded 270 basis points to 21.2%.
Adjusted EBITDA was $35.9 million, up 28.9% from the prior-year period’s levels. Adjusted EBITDA margins improved 290 bps to 23.8%.
Medical and Veterinary: Revenues in the segment increased 6.1% to $91.7 million from the year-ago quarter’s figure. Total student enrollment, however, fell 4.5% from the prior-year quarter’s levels to 5,073 students due to declines at the medical schools.
Adjusted operating income increased 35.9% from the prior-year quarter’s figure to $23 million. Adjusted operating margin expanded 550 basis points to 25%.
Adjusted EBITDA was $27 million, up 30.3% from the prior-year quarter’s levels. Adjusted EBITDA margins surged 540 bps to 29.4%.
Liquidity & Cash Flow
As of Mar 31, 2024, Adtalem had cash and cash equivalents of $179.8 million compared with $273.7 million at the end of fiscal 2023. Long-term debt was $648.1 million, down from $695.1 million at the end of fiscal 2023. Trailing 12-month net debt to adjusted EBITDA was 1.3x at March 2024-end versus 1.5x at 2023-end.
For the first nine months of fiscal 2024, net cash provided by operating activities (continuing operations) totaled $246.8 million compared with $149.8 million in the year-ago period. Free cash flow in the quarter was $142.1 million compared with $98.2 million a year ago.
Raised Fiscal 2024 Guidance
Adtalem now expects revenues in the range of $1.56-$1.58 billion, up from the prior expectation of $1.52-$1.56 billion. The updated guidance is up from the prior-year figure of $1.45 billion.
Adjusted EPS is now expected to be in the range of $4.80-$5.00 per share, up from the prior estimate of $4.55-$4.75. In the year-ago period, the company reported an adjusted EPS of $4.21.
Zacks Rank
Adtalem currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Recent Consumer Discretionary Releases
Leggett & Platt, Incorporated (LEG - Free Report) reported tepid first-quarter 2024 results, wherein earnings and net sales missed the Zacks Consensus Estimate. The metrics declined on a year-over-year basis due to persistent weak demand in most of the markets served and lower price realization.
Leggett significantly reduced its second-quarter dividend to 5 cents from the prior-year figure of 46 cents. The company noted that the move has been undertaken to free up capital to accelerate the deleveraging of its balance sheet and solidify long-held financial strength. The dividend will be paid on Jul 15, 2024, to shareholders of record on Jun 14.
Strategic Education, Inc. (STRA - Free Report) , or SEI, reported stellar results for first-quarter 2024. Its quarterly earnings and revenues topped the Zacks Consensus Estimate and increased year over year.
The quarterly results reflect solid growth across the company’s three reportable segments, attributable to continued enrollment growth in the U.S. Higher Education segment, especially employer-affiliated enrollments, and total enrollment improvement in the Australia/New Zealand segment.
Mohawk Industries, Inc. (MHK - Free Report) reported impressive earnings in first-quarter 2024 (ended Mar 30). Its earnings surpassed the Zacks Consensus Estimate and improved from the prior year on the back of lower input costs, less restructuring expenses and productivity gains.
On the other hand, net sales declined on a year-over-year basis but marginally beat the consensus mark.